Krilogy Financial LLC Makes New $799,000 Investment in DuPont de Nemours, Inc. $DD

Krilogy Financial LLC acquired a new stake in DuPont de Nemours, Inc. (NYSE:DDFree Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 10,257 shares of the basic materials company’s stock, valued at approximately $799,000.

A number of other hedge funds have also bought and sold shares of DD. Princeton Global Asset Management LLC boosted its position in DuPont de Nemours by 64.4% during the second quarter. Princeton Global Asset Management LLC now owns 365 shares of the basic materials company’s stock valued at $25,000 after acquiring an additional 143 shares during the last quarter. Salomon & Ludwin LLC lifted its stake in shares of DuPont de Nemours by 186.5% in the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company’s stock valued at $25,000 after purchasing an additional 207 shares during the period. Cary Street Partners Investment Advisory LLC boosted its position in shares of DuPont de Nemours by 67.5% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 541 shares of the basic materials company’s stock valued at $37,000 after purchasing an additional 218 shares in the last quarter. Crews Bank & Trust grew its stake in DuPont de Nemours by 55.8% during the third quarter. Crews Bank & Trust now owns 508 shares of the basic materials company’s stock worth $40,000 after purchasing an additional 182 shares during the period. Finally, Quaker Wealth Management LLC increased its holdings in DuPont de Nemours by 200.7% in the second quarter. Quaker Wealth Management LLC now owns 594 shares of the basic materials company’s stock worth $41,000 after purchasing an additional 1,184 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.

Insider Activity

In other news, SVP Erik T. Hoover sold 6,005 shares of the business’s stock in a transaction on Friday, November 28th. The shares were sold at an average price of $39.79, for a total transaction of $238,938.95. Following the completion of the transaction, the senior vice president directly owned 112,101 shares in the company, valued at $4,460,498.79. The trade was a 5.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Lori Koch sold 9,011 shares of the company’s stock in a transaction on Friday, November 28th. The stock was sold at an average price of $39.46, for a total transaction of $355,574.06. Following the completion of the transaction, the chief executive officer directly owned 288,326 shares in the company, valued at approximately $11,377,343.96. The trade was a 3.03% decrease in their position. The SEC filing for this sale provides additional information. 0.61% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms recently issued reports on DD. JPMorgan Chase & Co. boosted their target price on shares of DuPont de Nemours from $48.00 to $50.00 and gave the company an “overweight” rating in a research report on Friday, January 16th. Deutsche Bank Aktiengesellschaft cut their target price on DuPont de Nemours from $90.00 to $46.00 and set a “buy” rating on the stock in a report on Tuesday, November 25th. Zacks Research upgraded shares of DuPont de Nemours from a “strong sell” rating to a “hold” rating in a report on Friday, January 9th. UBS Group lifted their target price on DuPont de Nemours from $49.00 to $56.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, KeyCorp increased their target price on shares of DuPont de Nemours from $51.00 to $57.00 and gave the company an “overweight” rating in a report on Wednesday. Twelve analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $50.46.

View Our Latest Research Report on DuPont de Nemours

DuPont de Nemours Trading Up 1.5%

Shares of DuPont de Nemours stock opened at $50.19 on Friday. The stock has a market capitalization of $21.03 billion, a P/E ratio of -26.98, a P/E/G ratio of 1.24 and a beta of 1.10. DuPont de Nemours, Inc. has a 52-week low of $22.50 and a 52-week high of $52.66. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.63 and a current ratio of 2.42. The stock’s 50-day simple moving average is $43.29 and its 200 day simple moving average is $37.20.

DuPont de Nemours (NYSE:DDGet Free Report) last issued its earnings results on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.03. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.69 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The company’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter last year, the business earned $1.13 earnings per share. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. As a group, research analysts anticipate that DuPont de Nemours, Inc. will post 4.38 EPS for the current year.

DuPont de Nemours announced that its Board of Directors has authorized a share repurchase plan on Thursday, November 6th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the basic materials company to repurchase up to 12.2% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

DuPont de Nemours Profile

(Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Featured Articles

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DDFree Report).

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.